Article

Wearable Devices, mHealth Can Lead to True Patient Engagement

Smart watches, mHealth apps, and Bluetooth scales may just be edging into the social consciousness as a viable way to monitor personal health and manage chronic diseases, but EHR developers have been eyeing these technologies for some time, seeing them as valuable tools in the struggle to engage patients, prevent unnecessary readmissions, reduce costs, and promote long-term health.

Smart watches, mHealth apps, and Bluetooth scales may just be edging into the social consciousness as a viable way to monitor personal health and manage chronic diseases, but EHR developers have been eyeing these technologies for some time, seeing them as valuable tools in the struggle to engage patients, prevent unnecessary readmissions, reduce costs, and promote long-term health.

With Stage 2 of Meaningful Use bringing patient engagement to the forefront of providers’ minds, and a focus on accountable care making good outcomes profitable in a tangible way, healthcare organizations are making sure that they are equipped to guide their patients through the maze of quantifying and improving their own health.

As President of Population Health Management at Allscripts, Peter McClennen believes that a seamless, connected ecosystem of patient-centric technologies is the key to making an impact on healthcare delivery and the way patients interact with their providers. McClennen spoke to EHRintelligence about how wearable devices, mHealth apps, and patient portals will expand their role in the care continuum, allowing new methods of communication and more robust data for patients and providers alike.

Read the full story here: http://bit.ly/1wxyB7U

Source: EHR Intelligence

Related Videos
Jaime Almandoz, MD, MBA
Image credit: Medical technology and futuristic concept. Doctor hologram modern virtual screen interface | SOMKID - stock.adobe.com
Erin Weber, MS
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Erin Weber, MS
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
AJMC Q&A with Jason Bellet, Dr Geoffrey Rutledge, and Dan Nardi
Dan Nardi
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo